To validate the role of IL-9 in PD-1 overexpression in CD8+ cells in vivo, we carried out IL-9-blockade experiments in the aggressive CLL Eμ-TCL1/p66Shc−/− mouse model [17, 25]. This evidence concerns the gene IL9 and B-cell chronic lymphocytic leukemia.